Literature DB >> 18592174

Flow cytometric analysis of cell membrane microparticles.

Monique P Gelderman1, Jan Simak.   

Abstract

Cell membrane microparticles (MPs) are phospholipid microvesicles shed from the plasma membrane of most eukaryotic cells undergoing activation or apoptosis. The presence of MPs is common in healthy individuals. However, an increase in their release is a controlled event and is considered a hallmark of cellular alteration. Microparticles display cell surface proteins that indicate their cellular origin. In addition, they may also express other markers, e.g., markers of cellular activation. Elevated levels of circulating MPs are associated with various vascular pathologies and their pathogenic potential has been widely documented. MPs have been analyzed in plasma and cell cultures by means of flow cytometry or solid phase assays. Here we present a three-color flow cytometric assay for immunophenotyping of MPs in plasma. This assay has been used to study elevated counts of different phenotypes of circulating endothelial MPs in several hematological and vascular diseases. A modified version of this assay can also be used for MP analysis in blood products and cell cultures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18592174     DOI: 10.1007/978-1-59745-398-1_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  27 in total

Review 1.  Microparticles as mediators and biomarkers of rheumatic disease.

Authors:  David S Pisetsky; Anirudh J Ullal; Julie Gauley; Tony C Ning
Journal:  Rheumatology (Oxford)       Date:  2012-03-07       Impact factor: 7.580

2.  Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells.

Authors:  Julie A Mund; Myka L Estes; Mervin C Yoder; David A Ingram; Jamie Case
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-01-26       Impact factor: 8.311

3.  Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro.

Authors:  Li Sun; Hong-xiang Wang; Xiao-jian Zhu; Pin-hui Wu; Wei-qun Chen; Ping Zou; Qiu-bai Li; Zhi-chao Chen
Journal:  Acta Pharmacol Sin       Date:  2013-12-30       Impact factor: 6.150

Review 4.  Microparticle analysis in disorders of hemostasis and thrombosis.

Authors:  Micah J Mooberry; Nigel S Key
Journal:  Cytometry A       Date:  2015-02-20       Impact factor: 4.355

5.  Microparticle content of plasma for transfusion is influenced by the whole blood hold conditions: pre-analytical considerations for proteomic investigations.

Authors:  Rosemary L Sparrow; Kasey Sze-Kei Chan
Journal:  J Proteomics       Date:  2012-07-16       Impact factor: 4.044

6.  Plasma microparticles in Alzheimer's disease: The role of vascular dysfunction.

Authors:  Soheila Hosseinzadeh; Maryam Noroozian; Esmaeil Mortaz; Kazem Mousavizadeh
Journal:  Metab Brain Dis       Date:  2017-12-05       Impact factor: 3.584

Review 7.  Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers.

Authors:  Crislyn D'Souza-Schorey; James W Clancy
Journal:  Genes Dev       Date:  2012-06-15       Impact factor: 11.361

Review 8.  Assessing the immune status of critically ill trauma patients by flow cytometry.

Authors:  Joshua W Kuethe; Rachael Mintz-Cole; Bobby L Johnson; Emily F Midura; Charles C Caldwell; Barbara St Pierre Schneider
Journal:  Nurs Res       Date:  2014 Nov-Dec       Impact factor: 2.381

9.  Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro.

Authors:  Marina A Dobrovolskaia; Anil K Patri; Jan Simak; Jennifer B Hall; Jana Semberova; Silvia H De Paoli Lacerda; Scott E McNeil
Journal:  Mol Pharm       Date:  2011-11-10       Impact factor: 4.939

10.  Liquid crystal droplet-based amplification of microvesicles that are shed by mammalian cells.

Authors:  Lie Na Tan; Gregory J Wiepz; Daniel S Miller; Eric V Shusta; Nicholas L Abbott
Journal:  Analyst       Date:  2014-05-21       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.